NEW YORK (GenomeWeb) – GenMark Diagnostics reported today after the close of the market that its fourth quarter revenues rose 34 percent year over year.

For the three months ended Dec. 31, 2015, the company reported revenues of $13.2 million compared to $9.8 million in Q4 2014, beating analysts' consensus estimate of $12.3 million for the quarter. Product sales accounted for almost all of the revenue in the quarter, and the company said it placed 17 additional XT-8 analyzers in end-user laboratories for a total of 633 analyzers in the US market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.